Millipore Corporation (NYSE, S&P 500: MIL) provides products for bioscience research and biopharmaceutical manufacturing. The company assists pharmaceuticals with the drug production process by providing tools and expertise to optimize their manufacturing productivity, ensure the quality of their drugs, and increase production of drugs that are hard to manufacture. Millipore also helps scientists carry out their research by providing pre-made laboratory kits and filters and tests that can be used to separate substances for analysis and eliminte impurities. Millipore's largest customers include research departments at biotechnology and pharmaceutical companies, research laboratories, universities and governmental institutions. The company employs approximately 5,800 employees in more than 47 offices worldwide.
In 2009, MIL earned a net income of $179.2 million on $1.65 billion in total revenues. This represents a 28.6% increase in net income on a 3.2% increase in total revenue from 2008.
MIL has two operating segments, Bioprocess and Bioscience, which have been consolidated into a single reportable segment.
Due to the wide array of products that they offer, Millipore has a large number of competitors ranging from large manufacturer offering a broad portfolio to specialized companies that operate in niche markets. For its Bioprocess Division, competitors include GE Healthcare, Pall (PLL), and Sartorius. For its Bioscience Division, competitors include Invitrogen (IVGN), Qiagen N.V. (QGEN), Thermo Fisher Scientific (TMO), Sigma-Aldrich (SIAL), Techne (TECH), Bio-Rad Laboratories (BIO), Becton, Dickinson and Company (BDX), Whatman, Pall (PLL), and Sartorius.